ClinicalTrials.govpublic full text
mFOLFOXIRI Plus Bevacizumab for Organ Preservation in Locally Advanced Rectal Cancer
phase 2 study, rectal cancer, organ preservation, folfoxiri, bevacizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 829800
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.